CA2837488C - A method and device for determining content of the middle and protein bound uremic toxins in a biological fluid - Google Patents

A method and device for determining content of the middle and protein bound uremic toxins in a biological fluid Download PDF

Info

Publication number
CA2837488C
CA2837488C CA2837488A CA2837488A CA2837488C CA 2837488 C CA2837488 C CA 2837488C CA 2837488 A CA2837488 A CA 2837488A CA 2837488 A CA2837488 A CA 2837488A CA 2837488 C CA2837488 C CA 2837488C
Authority
CA
Canada
Prior art keywords
protein bound
uremic toxins
bound uremic
biological fluid
determining content
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2837488A
Other languages
English (en)
French (fr)
Other versions
CA2837488A1 (en
Inventor
Ivo Fridolin
Fredrik Uhlin
Jana Jerotskaja
Risto Tanner
Jurgen Arund
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OU OPTOFLUID TECHNOLOGIES
Original Assignee
OU OPTOFLUID TECHNOLOGIES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EEP201000056A external-priority patent/EE05676B1/xx
Priority claimed from EEP201000085A external-priority patent/EE05669B1/xx
Application filed by OU OPTOFLUID TECHNOLOGIES filed Critical OU OPTOFLUID TECHNOLOGIES
Publication of CA2837488A1 publication Critical patent/CA2837488A1/en
Application granted granted Critical
Publication of CA2837488C publication Critical patent/CA2837488C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Cell Biology (AREA)
  • Optics & Photonics (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • External Artificial Organs (AREA)
CA2837488A 2010-06-28 2011-06-28 A method and device for determining content of the middle and protein bound uremic toxins in a biological fluid Active CA2837488C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EEP201000056 2010-06-28
EEP201000056A EE05676B1 (et) 2010-06-28 2010-06-28 Optiline meetod ja seade keskmise suurusega ja valkudega seotud ureemiliste toksiinide m„„ramiseks bioloogilistes vedelikes
EEP201000085A EE05669B1 (et) 2010-12-10 2010-12-10 Optiline meetod ja seade keskmise suurusega ja valkudega seotud ureemiliste toksiinide m„„ramiseks bioloogilistes vedelikes
EEP201000085 2010-12-10
PCT/EE2011/000008 WO2012000521A1 (en) 2010-06-28 2011-06-28 A method and device for determining content of the middle and protein bound uremic toxins in a biological fluid

Publications (2)

Publication Number Publication Date
CA2837488A1 CA2837488A1 (en) 2012-01-05
CA2837488C true CA2837488C (en) 2021-10-26

Family

ID=44508544

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2837488A Active CA2837488C (en) 2010-06-28 2011-06-28 A method and device for determining content of the middle and protein bound uremic toxins in a biological fluid

Country Status (10)

Country Link
US (1) US9103789B2 (https=)
EP (1) EP2585830B1 (https=)
JP (1) JP5957450B2 (https=)
KR (1) KR101848527B1 (https=)
CN (1) CN102985822A (https=)
AU (1) AU2011274009B2 (https=)
BR (1) BR112012033625A2 (https=)
CA (1) CA2837488C (https=)
NZ (1) NZ605685A (https=)
WO (1) WO2012000521A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012112790A1 (de) * 2012-12-20 2014-06-26 B. Braun Avitum Ag Verfahren und Vorrichtung zur Bestimmung von Abfallprodukten wie Indoxyl Sulfate in der Dialyse
CN105264087B (zh) * 2013-02-19 2019-06-18 尼普洛株式会社 羟基吲哚硫酸的测定方法
CN104991026A (zh) * 2015-06-29 2015-10-21 苏州东辰林达检测技术有限公司 尿液中甲基马尿酸的检测方法
EP3537135A1 (en) * 2018-03-05 2019-09-11 Tallinn University of Technology A device and method for assessment of a concentration of free pentosidine in a spent dialysate
JP7207702B2 (ja) * 2018-11-06 2023-01-18 国立研究開発法人農業・食品産業技術総合研究機構 成分抽出方法、蛍光指紋測定装置、及びコンピュータが実行可能なプログラム
GB202104698D0 (en) * 2021-03-31 2021-05-12 Tallinn Univ Of Technology Multiparametric optical method and apparatus for the determination of uremic solutes, including uremic toxins, in biological fluids
TWI838830B (zh) * 2022-04-08 2024-04-11 財團法人工業技術研究院 β2-微球蛋白濃度的分析方法及裝置
CN120948421B (zh) * 2025-10-15 2026-02-06 天津医科大学 一种定量-判别一体化尿毒症智能检测系统

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3261264B2 (ja) 1994-07-13 2002-02-25 株式会社堀場製作所 多成分水溶液の分析方法およびその分析装置
WO1998019592A1 (en) * 1996-11-01 1998-05-14 Rio Grande Medical Technologies, Inc. Dialysis monitoring method and apparatus
US6261848B1 (en) 1998-05-08 2001-07-17 The Johns Hopkins University Miniature immuno-optical rapid analyte sensor platform
SE525639C2 (sv) 1998-06-04 2005-03-22 Thore Falkvall Bestämning av slaggprodukter i dialysvätska med hjälp av optisk sensor
AUPR748501A0 (en) * 2001-09-04 2001-09-27 Life Therapeutics Limited Renal dialysis
US8337444B2 (en) * 2001-05-22 2012-12-25 Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California Measurement of cardiac output and blood volume by non-invasive detection of indicator dilution for hemodialysis
RU2212029C1 (ru) 2001-12-03 2003-09-10 Общество с ограниченной ответственностью "Клиника экстракорпоральной гемокоррекции" Способ анализа жидкой биологической среды в процессе мониторинга
US7002670B2 (en) * 2002-06-12 2006-02-21 Baxter International Inc. Optical sensor and method for measuring concentration of a chemical constituent using its intrinsic optical absorbance
WO2005003744A1 (ja) * 2003-07-03 2005-01-13 Wako Pure Chemical Industries, Ltd. 分光測定による特定成分の測定方法
US7427508B2 (en) 2003-10-09 2008-09-23 Organotek Defense System Corporation Method for assaying multi-component mixtures
WO2005069737A2 (en) * 2004-01-27 2005-08-04 Ramot At Tel Aviv University Ltd. Method and system for detecting analytes
EP1751523B1 (en) 2004-05-13 2017-10-04 NarTest AS A portable device and method for on-site detection and quantification of drugs
US7966051B2 (en) * 2005-01-11 2011-06-21 Olympus Corporation Fluorescent agent concentration measuring apparatus, dose control apparatus, administration system, fluorescent agent concentration measuring method, and dose control method
DE102005020384A1 (de) * 2005-05-02 2006-11-09 Therainvention Gmbh Spektroskopisches Verfahren zum Nachweis von Analyten
WO2009071102A1 (en) 2007-12-04 2009-06-11 Tallinn University Of Technology Optical method and device for measuring concentrations of substances in biological fluids

Also Published As

Publication number Publication date
AU2011274009A1 (en) 2013-01-31
JP2013534630A (ja) 2013-09-05
JP5957450B2 (ja) 2016-07-27
NZ605685A (en) 2014-10-31
CA2837488A1 (en) 2012-01-05
EP2585830B1 (en) 2018-04-25
AU2011274009B2 (en) 2016-06-23
BR112012033625A2 (pt) 2016-10-25
KR101848527B1 (ko) 2018-04-12
CN102985822A (zh) 2013-03-20
WO2012000521A1 (en) 2012-01-05
KR20130038347A (ko) 2013-04-17
EP2585830A1 (en) 2013-05-01
US20130193347A1 (en) 2013-08-01
US9103789B2 (en) 2015-08-11

Similar Documents

Publication Publication Date Title
CA2837488C (en) A method and device for determining content of the middle and protein bound uremic toxins in a biological fluid
WO2022208445A3 (en) Multiparametric optical method and device for determining uremic solutes, including uremix toxins, in biological fluids
WO2013190075A3 (en) Specific biomarkers for hepatocellular carcinoma (hcc)
WO2012162165A3 (en) Antibodies to 25-hydroxyvitamin d2 and d3 and uses thereof
MX344268B (es) Proceso para purificacion de proteinas.
BRPI0810744A2 (pt) Moléculas absorventes de oxigênio, objetos que as contêm, e métodos de sua utilização
EA201171178A1 (ru) Устройство и способ для определения и количественного анализа аналитов, в частности, микотоксинов
MX347754B (es) Desarrollo y uso de sondas fluorescentes de bilirrubina sin enlazar.
WO2007098444A3 (en) Methods for analysis of extracellular rna species
TR201820019T4 (tr) Metilglioksal hidroimidazolonun (MGH1) belirlenmesi aracılığıyla diyabet yönetiminin geliştirilmesine yönelik yöntem ve kit.
PL2005164T3 (pl) Test fluorescencyjny
WO2008012650A3 (en) An immunochromatography device for the diagnosis of diseases in a sample
CY1112423T1 (el) Αναλυτικη συσκευη μικροεπεξεργαστη μιας χρησης
RU2013138721A (ru) Способы и наборы для прогнозирования риска дыхательной недостаточности, почечной недостаточности или тромбопении у пациента, страдающего сепсисом, путем измерения уровней эндокана в крови
EP2281186A4 (en) DEVICE AND METHOD FOR OPTICALLY DETECTING THE CONCENTRATION OF AN ANALYTE IN A FLUID CONTAINING ERYTHROCYTES
MY157846A (en) Process for the purification of fc-containing proteins
RU2015108756A (ru) Применение антиоксидантов в способах и средствах для детектирования молекул-мишений в пробе крови
GB2522131A (en) Isotopic labelling of proteins
NO20081794L (no) Fremgangsmate for kvantitativ bestemmelse av poloxamere
DE602006015727D1 (de) Verfahren zur messung von plasmaspiegeln von pentraxin ptx3
ZA200800253B (en) Method for the quantitative determination of poloxamers
WO2008125738A8 (en) A method for selecting responders to blockade of integrin receptors
WO2012077983A3 (ko) Ape1/ref-1을 함유하는 방광암 진단용 조성물, 및 이를 이용한 방광암 진단 키트
WO2010093214A3 (en) Monoclonal antibody recognizing scye1 and use thereof
UA11184U (uk) Спосіб гасіння власної флуоресценції білків

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20160530

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 14TH ANNIV.) - SMALL

Year of fee payment: 14

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250523

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250523